These results suggest that TEM1 might also be a promising therapeutic target for carcinoma by targeting CAFs, rather than tumor cells, however, these TEM1 expression statuses in CAFs were not independent risk factors for RFS, OS, or COS (Table S3). Here, CD248 is linked to neoplasm.